# SL Green Realty Corp: financial statements, quarterly

SLG · NYSE · CIK 1040971 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/slg.md) · [Financials](/companies/slg/financials.md) · [Filings](/companies/slg/filings.md) · [Insiders](/companies/slg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/slg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [246](/filings/0001040971-24-000025.md) | [210](/filings/0001040971-24-000031.md) | [212 d](/filings/0001628280-26-008669.md) | [188](/filings/0001040971-25-000022.md) | [223](/filings/0001040971-25-000031.md) | [230](/filings/0001628280-25-047886.md) | [246 d](/filings/0001628280-26-008669.md) | [240](/filings/0001628280-26-029075.md) | [242](/filings/0001040971-25-000031.md) | [245](/filings/0001628280-25-047886.md) | [276 d](/filings/0001628280-26-008669.md) | [253](/filings/0001628280-26-029075.md) |
| Selling, general and administrative | $m | [23.0](/filings/0001040971-24-000025.md) | [22.9](/filings/0001040971-24-000031.md) | [42.3 d](/filings/0001628280-26-008669.md) | [21.3](/filings/0001040971-25-000022.md) | [20.0](/filings/0001040971-25-000031.md) | [21.0](/filings/0001628280-25-047886.md) | [22.8 d](/filings/0001628280-26-008669.md) | [21.7](/filings/0001628280-26-029075.md) | [21.6](/filings/0001040971-25-000031.md) | [23.7](/filings/0001628280-25-047886.md) | [22.3 d](/filings/0001628280-26-008669.md) | [22.8](/filings/0001628280-26-029075.md) |
| Operating income | $m | not reported | not reported | not reported | [258](/filings/0001040971-25-000022.md) | [176](/filings/0001040971-25-000031.md) | [149](/filings/0001628280-25-047886.md) | [147 d](/filings/0001628280-26-008669.md) | [136](/filings/0001628280-26-029075.md) | [129](/filings/0001040971-25-000031.md) | [209](/filings/0001628280-25-047886.md) | [177 d](/filings/0001628280-26-008669.md) | [145](/filings/0001628280-26-029075.md) |
| Interest expense | $m | [65.9](/filings/0001040971-24-000025.md) | [52.9](/filings/0001040971-24-000031.md) | [45.2 d](/filings/0001628280-26-008669.md) | [48.9](/filings/0001040971-24-000018.md) | [49.5](/filings/0001040971-24-000025.md) | [51.3](/filings/0001040971-24-000031.md) | [46.6 d](/filings/0001628280-26-008669.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.0](/filings/0001040971-24-000025.md) | [2.5](/filings/0001040971-24-000031.md) | [4.0 d](/filings/0001040971-25-000019.md) | [0.7](/filings/0001040971-25-000022.md) | [0.9](/filings/0001040971-25-000031.md) | [1.1](/filings/0001628280-25-047886.md) | [(2.0) d](/filings/0001040971-25-000019.md) | [0.5](/filings/0001040971-25-000022.md) | [1.2](/filings/0001040971-25-000031.md) | [(0.1)](/filings/0001628280-25-047886.md) | not reported | not reported |
| Net income | $m | [(356)](/filings/0001040971-24-000025.md) | [(20.2)](/filings/0001040971-24-000031.md) | [(152) d](/filings/0001628280-26-008669.md) | [16.9](/filings/0001040971-25-000022.md) | [1.6](/filings/0001040971-25-000031.md) | [(9.5)](/filings/0001628280-25-047886.md) | [13.1 d](/filings/0001628280-26-008669.md) | [(17.3)](/filings/0001628280-26-029075.md) | [(7.4)](/filings/0001040971-25-000031.md) | [28.6](/filings/0001628280-25-047886.md) | [(101) d](/filings/0001628280-26-008669.md) | [(80.7)](/filings/0001628280-26-029075.md) |
| Diluted EPS | $ per share | [(5.63)](/filings/0001040971-24-000025.md) | [(0.38)](/filings/0001040971-24-000031.md) | not reported | [0.20](/filings/0001040971-25-000022.md) | [(0.04)](/filings/0001040971-25-000031.md) | [(0.21)](/filings/0001628280-25-047886.md) | not reported | [(0.30)](/filings/0001628280-26-029075.md) | [(0.16)](/filings/0001040971-25-000031.md) | [0.34](/filings/0001628280-25-047886.md) | not reported | [(1.20)](/filings/0001628280-26-029075.md) |
| Basic EPS | $ per share | [(5.63)](/filings/0001040971-24-000025.md) | [(0.38)](/filings/0001040971-24-000031.md) | not reported | [0.20](/filings/0001040971-25-000022.md) | [(0.04)](/filings/0001040971-25-000031.md) | [(0.21)](/filings/0001628280-25-047886.md) | not reported | [(0.30)](/filings/0001628280-26-029075.md) | [(0.16)](/filings/0001040971-25-000031.md) | [0.35](/filings/0001628280-25-047886.md) | not reported | [(1.20)](/filings/0001628280-26-029075.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001040971-24-000025.md) | [0.2](/filings/0001040971-24-000031.md) | [0.2](/filings/0001628280-26-008669.md) | [0.2](/filings/0001040971-25-000022.md) | [0.2](/filings/0001040971-25-000031.md) | [0.2](/filings/0001628280-25-047886.md) | [0.2](/filings/0001628280-26-008669.md) | [0.2](/filings/0001628280-26-029075.md) | [0.2](/filings/0001040971-25-000031.md) | [0.2](/filings/0001628280-25-047886.md) | [0.2](/filings/0001628280-26-029075.md) | [0.1](/filings/0001628280-26-029075.md) |
| Total assets | $bn | [10.0](/filings/0001040971-23-000031.md) | [9.7](/filings/0001040971-23-000040.md) | [9.5](/filings/0001040971-25-000019.md) | [9.8](/filings/0001040971-24-000018.md) | [9.5](/filings/0001040971-24-000025.md) | [10.2](/filings/0001040971-24-000031.md) | [10.5](/filings/0001628280-26-008669.md) | [11.4](/filings/0001040971-25-000022.md) | [11.3](/filings/0001040971-25-000031.md) | [11.1](/filings/0001628280-25-047886.md) | [11.1](/filings/0001628280-26-029075.md) | [11.8](/filings/0001628280-26-029075.md) |
| Total liabilities | $bn | [5.5](/filings/0001040971-23-000031.md) | [5.2](/filings/0001040971-23-000040.md) | [5.3](/filings/0001040971-25-000019.md) | [5.5](/filings/0001040971-24-000018.md) | [5.4](/filings/0001040971-24-000025.md) | [6.1](/filings/0001040971-24-000031.md) | [5.9](/filings/0001628280-26-008669.md) | [7.0](/filings/0001040971-25-000022.md) | [6.9](/filings/0001040971-25-000031.md) | [6.7](/filings/0001628280-25-047886.md) | [6.7](/filings/0001628280-26-029075.md) | [7.4](/filings/0001628280-26-029075.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [4.1](/filings/0001040971-23-000031.md) | [4.0](/filings/0001040971-23-000040.md) | [3.8](/filings/0001040971-25-000019.md) | [3.7](/filings/0001040971-24-000018.md) | [3.7](/filings/0001040971-24-000025.md) | [3.6](/filings/0001040971-24-000031.md) | [4.0](/filings/0001628280-26-008669.md) | [3.8](/filings/0001040971-25-000022.md) | [3.8](/filings/0001040971-25-000031.md) | [3.8](/filings/0001628280-25-047886.md) | [3.7](/filings/0001628280-26-029075.md) | [3.5](/filings/0001628280-26-029075.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [61.6 d](/filings/0001040971-24-000025.md) | [77.3 d](/filings/0001040971-24-000031.md) | [48.2 d](/filings/0001628280-26-008669.md) | [(24.7)](/filings/0001040971-25-000022.md) | [79.4 d](/filings/0001040971-25-000031.md) | [16.7 d](/filings/0001628280-25-047886.md) | [58.2 d](/filings/0001628280-26-008669.md) | [6.7](/filings/0001628280-26-029075.md) | [54.5 d](/filings/0001040971-25-000031.md) | [(6.8) d](/filings/0001628280-25-047886.md) | [28.5 d](/filings/0001628280-26-008669.md) | [(17.6)](/filings/0001628280-26-029075.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [57.6 d](/filings/0001040971-24-000025.md) | [57.9 d](/filings/0001040971-24-000031.md) | [58.0 d](/filings/0001628280-26-008669.md) | [54.1](/filings/0001040971-25-000022.md) | [54.3 d](/filings/0001040971-25-000031.md) | [54.3 d](/filings/0001628280-25-047886.md) | [56.0 d](/filings/0001628280-26-008669.md) | [60.2](/filings/0001628280-26-029075.md) | [60.2 d](/filings/0001040971-25-000031.md) | [60.6 d](/filings/0001628280-25-047886.md) | [61.7 d](/filings/0001628280-26-008669.md) | [2.8](/filings/0001628280-26-029075.md) |
| Share repurchases | $m | [0.0 d](/filings/0001040971-23-000031.md) | [0.0 d](/filings/0001040971-23-000040.md) | [0.0 d](/filings/0001040971-25-000019.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [69.0](/filings/0001040971-23-000031.md) | [68.9](/filings/0001040971-23-000040.md) | [68.2](/filings/0001040971-24-000018.md) | [68.3](/filings/0001040971-24-000025.md) | [68.3](/filings/0001040971-24-000031.md) | [70.1](/filings/0001040971-25-000022.md) | [68.7](/filings/0001040971-25-000031.md) | [64.4](/filings/0001628280-25-047886.md) | [70.4](/filings/0001628280-26-029075.md) | [70.4](/filings/0001040971-25-000031.md) | [71.1](/filings/0001628280-25-047886.md) | [70.7](/filings/0001628280-26-029075.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 71,124,483 at 2026-04-29, from the cover of the [10-Q filed 2026-05-01](/filings/0001628280-26-029075.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.